Please find below the overview of all published, ongoing and planned guidelines
Updated 08.11.2025
Title | Author | Journal, Year | WG/TF/Collaboration |
Torra et al. | Nephrol Dial Transplant, 2025
| Hereditary Glomerulopathies ERA, ESPN | |
K. Abrahamson et al. | EAU Guidelines Office 2025 | CAKUT eUROGEN, ERN-ITHACA, EAU, ESPU | |
D. Bökenkamp et al. | Nephrol Dial Transplant 2025 | Metabolic Nephropathies, Tubulopathies ESPN | |
E. Levtchenko et al. | Nat Rev Nephrol. 2024 | Tubulopathies ESPN | |
A. Servais et al. | Kidney Int. Rep. 2024 | Metabolic and Stone Disorders, Tubulopathies Metab-ERN | |
D. Mekahli et al. | Nat Rev Nephrol. 2024 | AD structural kidney disorders ERA | |
D. Reijman et al | Atherosclerosis 2024 | Pediatric CKD/Dialysis ESPN | |
H. Dollfus et al. | CAKUT and obstructive nephropathies ERN-Eye, Endo-ERN, ERN-ITHACA | ||
J.W.Groothoff et al. | Nat Rev Nephrol. 2023 | Metabolic and Stone Disorders Oxaleurope | |
R. Müller et al. | Nephrol Dial Transplant 2022 | AD structural kidney disorders ERA | |
V. Capone et al. | Nat Rev Urol. 2022 | CAKUT and obstructive nephropathies eUROGEN | |
S. Kohl et al. | Nephrol Dial Transplant 2022 | CAKUT and obstructive nephropathies | |
Genetic testing in the diagnosis of CKD | N.Knoers et al. | Nephrol Dial Transplant 2022 | TF Molecular Diagnostics |
A.Servais et al. | Kidney Int. 2021 | Metabolic and Stone Disorders | |
M. Konrad et al. | Kidney Int. 2021 | Tubulopathies | |
F. Trepiccione et al. | Nephrol Dial Transplant 2021 | Tubulopathies ESPN | |
L. Weber et al. | Pediatr Transplant. 2021 | Pediatric Tx CERTAIN | |
O. Boyer et al. | Nat Rev Nephrol. 2021 | Hereditary Glomerulopathies ESPN | |
B. Lipska-Zietkiewicz et al. | Eur J Hum Genet. 2020 | Hereditary Glomerulopathies ESPN |
Updated 07.11.2025
Title | Working Group | Collaboration | Status |
Cardiovascular evaluation and management in ped CKD | PedCKD&Dialysis | ESPN | Delphi Round, expected Q1 2026 |
ARPKD | CAKUT and Ciliopathies | ESPN | Delphi Round, expected Q1 2026 |
Attenuation of CKD progression in ped CKD | PedCKD&Dialysis | ESPN | First version of manuscript, circulated to authors, expected Q1 2026 |
Monoclonal gammopathies of renal significance | Immune glomerulopathies | EuroBloodNet | First version of manuscript, circulated to authors, expected Q1 2026 |
Lowe Syndrome | Metabolic nephropathies | ESPN | First version of manuscript in preparation, expected Q1 2026 |
William Beuren Syndrome | CAKUT and Ciliopathies | ERN-ITHACA | Writing draft recommendation |
Congenital TTP | TMA | ESPN | Writing draft recommendation, expected Q2 2026 |
Hypomagnesemia | Tubulopathies | ERA | Writing draft recommendation, expected Q2 2026 |
Megaureter | CAKUT and Ciliopathies | eUROGEN | Writing draft recommendation, expected Q2 2026 |
Nephrocalcinosis | Tubulopathies |
| Writing draft recommendation, expected Q2 2026 |
Renal Replacement Therapy | Pediatric CKD/Dialysis | ESPN | Litrature screenining, expected Q4 2026 |
Belzutifan in von-Hippel-Lindau-Disease | AD Structural Disorders | ERA, eUROGEN, Endo-ERN, ERN-Eye, Genturis | Definiton PICO questions, expected Q4 2026 |
Postnatal PUV | CAKUT/Ciliopathies | (eUROGEN) | In planning, expected Q1 2027 |
VUR high-grade | CAKUT/Ciliopathies | (eUROGEN) | In planning, expected Q1 2027 |